 Anti-Citrullinated Protein Antibodies
"Anti-Citrullinated Protein Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoantibodies to citrullinated-peptides and proteins.
| Descriptor ID |
D000075422
|
| MeSH Number(s) |
D12.776.124.486.485.114.323.095 D12.776.124.790.651.114.323.095 D12.776.377.715.548.114.323.095
|
| Concept/Terms |
Anti-Citrullinated Protein Antibodies- Anti-Citrullinated Protein Antibodies
- Anti Citrullinated Protein Antibodies
- Antibodies, Anti-Citrullinated Protein
- Protein Antibodies, Anti-Citrullinated
- Citrullinated Protein Antibodies
- Antibodies, Citrullinated Protein
- Protein Antibodies, Citrullinated
- Anti-Citrullinated Peptide Antibodies
- Anti Citrullinated Peptide Antibodies
- Antibodies, Anti-Citrullinated Peptide
- Peptide Antibodies, Anti-Citrullinated
|
Below are MeSH descriptors whose meaning is more general than "Anti-Citrullinated Protein Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Anti-Citrullinated Protein Antibodies".
This graph shows the total number of publications written about "Anti-Citrullinated Protein Antibodies" by people in this website by year, and whether "Anti-Citrullinated Protein Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 | | 2017 | 2 | 0 | 2 | | 2018 | 5 | 0 | 5 | | 2019 | 4 | 2 | 6 | | 2020 | 3 | 3 | 6 | | 2021 | 2 | 1 | 3 | | 2022 | 0 | 1 | 1 | | 2023 | 1 | 3 | 4 | | 2024 | 3 | 1 | 4 | | 2025 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Citrullinated Protein Antibodies" by people in Profiles.
-
Inamo J, Keegan J, Griffith A, Ghosh T, Horisberger A, Howard K, Pulford JF, Murzin E, Hancock B, Dominguez ST, Gurra MG, Gurajala S, Jonsson AH, Seifert JA, Feser ML, Norris JM, Cao Y, Apruzzese W, Bridges SL, Bykerk VP, Goodman S, Donlin LT, Firestein GS, Bathon JM, Hughes LB, Filer A, Pitzalis C, Anolik JH, Moreland L, Hacohen N, Guthridge JM, James JA, Cuda CM, Perlman H, Brenner MB, Raychaudhuri S, Sparks JA, Holers VM, Deane KD, Lederer J, Rao DA, Zhang F. Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. J Clin Invest. 2025 Mar 17; 135(6).
-
Lamacchia C, Aymon R, Hattel BC, Aeby S, Kebbi-Beghdadi C, Gilbert B, Studer O, Norris JM, Nolers VM, Demoruelle MK, Feser ML, Moss LK, Courvoisier DS, Lauper K, Deane KD, Greub G, Finckh A. A potential role for chlamydial infection in rheumatoid arthritis development. Rheumatology (Oxford). 2025 01 01; 64(1):252-260.
-
Nelson HA, Martins TB, Saadalla A, Nandakumar V. Evaluation of the clinical performance of anti-mutated citrullinated vimentin antibody and 14-3-3 eta testing in rheumatoid arthritis. Clin Chem Lab Med. 2025 Mar 26; 63(4):790-796.
-
Holers VM, Demoruelle KM, Buckner JH, James EA, Firestein GS, Robinson WH, Steere AC, Zhang F, Norris JM, Kuhn KA, Deane KD. Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis. Nat Rev Rheumatol. 2024 Oct; 20(10):601-613.
-
Takada H, Demoruelle MK, Deane KD, Nakamura S, Katsumata Y, Ikari K, Buckner JH, Robinson WH, Seifert JA, Feser ML, Moss L, Norris JM, Harigai M, Hsieh EWY, Holers VM, Okamoto Y. Expansion of HLA-DR Positive Peripheral Helper T and Naive B Cells in Anticitrullinated Protein Antibody-Positive Individuals At Risk for Rheumatoid Arthritis. Arthritis Rheumatol. 2024 Jul; 76(7):1023-1035.
-
Nelson HA, Novis CL, Lebiedz-Odrobina D, Nandakumar V. Performance of Anti-Carbamylated Protein Antibody Testing in the Routine Evaluation of Rheumatoid Arthritis from a Single Center. J Appl Lab Med. 2024 03 01; 9(2):251-261.
-
Demoruelle MK. The Changing Paradigm of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis. Arthritis Rheumatol. 2024 02; 76(2):178-180.
-
Holers VM. Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis? Semin Arthritis Rheum. 2024 02; 64S:152324.
-
Moore RE, Wang T, Duvvuri B, Feser ML, Deane KD, Solomon JJ, Nelson JL, Demoruelle MK, Lood C. Prediction of Erosive Disease Development by Antimitochondrial Antibodies in Rheumatoid Arthritis. Arthritis Rheumatol. 2023 06; 75(6):890-899.
-
Seifert JA, Bemis EA, Ramsden K, Lowell C, Polinski K, Feser M, Fleischer C, Demoruelle MK, Buckner J, Gregersen PK, Keating RM, Mikuls TR, O'Dell JR, Weisman MH, Deane KD, Norris JM, Steere AC, Holers VM. Association of Antibodies to Prevotella copri in Anti-Cyclic Citrullinated Peptide-Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis. Arthritis Rheumatol. 2023 04; 75(4):507-516.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|